Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action
Authors
Keywords
-
Journal
METABOLIC BRAIN DISEASE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-19
DOI
10.1007/s11011-020-00667-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
- (2020) Tommaso Cassano et al. Frontiers in Pharmacology
- Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
- (2020) Rafael G. Dos Santos et al. Expert Opinion on Drug Metabolism & Toxicology
- Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes
- (2020) Yane Costa Chaves et al. NEUROSCIENCE LETTERS
- Diabetic encephalopathy: beneficial effects of supplementation with fatty acids ω3 and nordihydroguaiaretic acid in a spontaneous diabetes rat model
- (2019) Gustavo Tomás Díaz-Gerevini et al. Lipids in Health and Disease
- Anxiety disorders and medical illness comorbidity and treatment implications
- (2019) Milan Latas et al. CURRENT OPINION IN PSYCHIATRY
- Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
- (2019) Arulkumar Nagappan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors
- (2019) Carlos Henrique Alves Jesus et al. BRAIN RESEARCH
- Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
- (2019) Gabriela Pandini Silote et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Rotenone protects against β-cell apoptosis and attenuates type 1 diabetes mellitus
- (2019) Mengqiu Wu et al. APOPTOSIS
- Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans
- (2019) Verity L. Chadwick et al. CURRENT OPINION IN PSYCHIATRY
- Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications
- (2019) Vivek S. Kumawat et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Activation of mineralocorticoid receptors facilitate the acquisition of fear memory extinction and impair the generalization of fear memory in diabetic animals
- (2019) Thiago Oliari Ribeiro et al. PSYCHOPHARMACOLOGY
- Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin
- (2018) O.M. Abdelwahed et al. BRAIN RESEARCH BULLETIN
- Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis
- (2018) K. J. Smith et al. DIABETIC MEDICINE
- Prevalence of mental disorders and related functioning and treatment engagement among people with diabetes
- (2018) Matthew Tyler Boden JOURNAL OF PSYCHOSOMATIC RESEARCH
- The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes
- (2018) Mariana Machado Pereira et al. METABOLIC BRAIN DISEASE
- Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
- (2018) Amanda J. Sales et al. MOLECULAR NEUROBIOLOGY
- Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models
- (2018) Slava Rom et al. MOLECULAR NEUROBIOLOGY
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats
- (2018) Helen de Morais et al. NEUROSCIENCE LETTERS
- Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
- (2018) Amanda J. Sales et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Posttraumatic stress disorder-type behaviors in streptozotocin-induced diabetic rats can be prevented by prolonged treatment with vitamin E
- (2018) Camila Pasquini de Souza et al. BEHAVIOURAL BRAIN RESEARCH
- The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations
- (2018) Fatemeh Delkhosh-Kasmaie et al. BIOMEDICINE & PHARMACOTHERAPY
- Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain
- (2018) Danilo De Gregorio et al. PAIN
- Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
- (2018) José A. Crippa et al. Frontiers in Immunology
- Associations among comorbid anxiety, psychiatric symptomatology, and diabetic control in a population with serious mental illness and diabetes: Findings from an interventional randomized controlled trial
- (2017) Awais Aftab et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat
- (2017) Xiaowen Han et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder
- (2017) Gislaine Z. Réus et al. LIFE SCIENCES
- The endocannabinoid system as a target for novel anxiolytic drugs
- (2017) Sachin Patel et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Telmisartan attenuates diabetes induced depression in rats
- (2017) Urmila Aswar et al. Pharmacological Reports
- Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
- (2017) Debra A. Kendall et al. Frontiers in Cellular Neuroscience
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus
- (2016) Joshua J. Joseph et al. Annals of the New York Academy of Sciences
- Effect of omega-3 polyunsaturated fatty acid treatment over mechanical allodynia and depressive-like behavior associated with experimental diabetes
- (2016) Daiany D.B. Redivo et al. BEHAVIOURAL BRAIN RESEARCH
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
- (2016) Wilma Helena Oliveira et al. BRAIN RESEARCH
- The CB2 receptor and its role as a regulator of inflammation
- (2016) Caroline Turcotte et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats
- (2016) Rafeek Hidhayath Basha et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Trajectories of depression in adults with newly diagnosed type 1 diabetes: results from the German Multicenter Diabetes Cohort Study
- (2016) Hanna Kampling et al. DIABETOLOGIA
- Depression: a common and burdensome complication of diabetes that warrants the continued attention of clinicians, researchers and healthcare policy makers
- (2016) François Pouwer DIABETOLOGIA
- Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists
- (2016) Mojgan Aghazadeh Tabrizi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The central cannabinoid receptor type-2 (CB2) and chronic pain
- (2016) Yuchao Shang et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
- (2016) Angélica Pupin Schiavon et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
- (2016) Mohamad Elbaz et al. Oncotarget
- Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
- (2016) Gemma Navarro et al. Frontiers in Neuroscience
- Role of the endocannabinoid system in diabetes and diabetic complications
- (2015) G Gruden et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diabetes-associated depression: The serotonergic system as a novel multifunctional target
- (2015) Deepali Gupta et al. INDIAN JOURNAL OF PHARMACOLOGY
- Reestablishment of the hyperglycemia to the normal levels seems not to be essential to the anxiolytic-like effect induced by insulin
- (2015) Eder Gambeta et al. METABOLIC BRAIN DISEASE
- Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes
- (2015) Isabella Caroline da Silva Dias et al. MOLECULAR NEUROBIOLOGY
- The endocannabinoid system in guarding against fear, anxiety and stress
- (2015) Beat Lutz et al. NATURE REVIEWS NEUROSCIENCE
- The link between depression and diabetes: the search for shared mechanisms
- (2015) Calum D Moulton et al. Lancet Diabetes & Endocrinology
- β-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in streptozotocin-induced diabetic rats
- (2014) Rafeek Hidhayath Basha et al. ACTA HISTOCHEMICA
- A role for trans-caryophyllene in the moderation of insulin secretion
- (2014) Wang Suijun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
- (2014) Alexandre Schier et al. CNS & Neurological Disorders-Drug Targets
- Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases
- (2014) Federico Carbone et al. CURRENT MEDICINAL CHEMISTRY
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system
- (2014) Deepali Gupta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of Resveratrol on Behavioral Performanceof Streptozotocin-induced Diabetic Mice inAnxiety Tests
- (2014) Juan P. Damián et al. EXPERIMENTAL ANIMALS
- Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy
- (2014) María Muriach et al. Oxidative Medicine and Cellular Longevity
- Psychiatric comorbidity in diabetes type 1: a cross-sectional observational study
- (2014) Ana Claudia C. de Ornelas Maia et al. Revista da Associacao Medica Brasileira
- Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats
- (2013) Helen de Morais et al. BEHAVIOURAL BRAIN RESEARCH
- Antidepressant use and new-onset diabetes: a systematic review and meta-analysis
- (2013) Sandipan Bhattacharjee et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Interactions Between Diabetes and Anxiety and Depression
- (2013) Alexander Bystritsky et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans
- (2013) Richard L. Anderson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
- (2013) M.V. Fogaça et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The impact of knowledge about diabetes, resilience and depression on glycemic control: a cross-sectional study among adolescents and young adults with type 1 diabetes
- (2013) Fabio R Munhoz Santos et al. Diabetology & Metabolic Syndrome
- Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
- (2012) Sabine Steffens et al. BRITISH JOURNAL OF PHARMACOLOGY
- Epidemiology of depression and diabetes: A systematic review
- (2012) Tapash Roy et al. JOURNAL OF AFFECTIVE DISORDERS
- Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: The role of serotonin and different forebrain neuronal subpopulations
- (2012) M. Häring et al. NEUROPHARMACOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.
- (2011) Gislaine Z. Réus et al. ACTA NEUROPSYCHIATRICA
- The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
- (2011) Béla Horváth et al. AMERICAN JOURNAL OF PATHOLOGY
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans
- (2011) C. Li et al. DIABETES OBESITY & METABOLISM
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- (2011) George W. Booz FREE RADICAL BIOLOGY AND MEDICINE
- Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells
- (2010) Chen Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Inflammation-associated depression: From serotonin to kynurenine
- (2010) Robert Dantzer et al. PSYCHONEUROENDOCRINOLOGY
- The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
- (2010) Felipe V. Gomes et al. PSYCHOPHARMACOLOGY
- Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice
- (2010) Tommaso Cassano et al. PSYCHOPHARMACOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
- (2009) Francis Rodriguez Bambico et al. CURRENT PHARMACEUTICAL DESIGN
- The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
- (2009) Matthew N. Hill et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mental disorders among persons with diabetes—Results from the World Mental Health Surveys
- (2008) Elizabeth H.B. Lin et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More